Jane Street’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.21M | Sell |
6,211
-1,378
| -18% | -$286K | ﹤0.01% | 6135 |
|
|
2026
Q1 | $1.7M | Buy |
7,589
+1,634
| +27% | +$407K | ﹤0.01% | 5398 |
|
|
2025
Q4 | $1.43M | Sell |
5,955
-28,550
| -83% | -$7.3M | ﹤0.01% | 5410 |
|
|
2025
Q3 | $9.45M | Sell |
34,505
-5,246
| -13% | -$1.43M | ﹤0.01% | 2503 |
|
|
2025
Q2 | $10.3M | Buy |
39,751
+3,102
| +8% | +$740K | ﹤0.01% | 2126 |
|
|
2025
Q1 | $8.2M | Buy |
36,649
+14,867
| +68% | +$3.47M | ﹤0.01% | 2248 |
|
|
2024
Q4 | $4.98M | Sell |
21,782
-40,755
| -65% | -$9.81M | ﹤0.01% | 2665 |
|
|
2024
Q3 | $15.3M | Sell |
62,537
-183,614
| -75% | -$41M | ﹤0.01% | 1480 |
|
|
2024
Q2 | $47.1M | Buy |
246,151
+161,964
| +192% | +$32.9M | 0.01% | 720 |
|
|
2024
Q1 | $16.7M | Sell |
84,187
-445,696
| -84% | -$81.7M | ﹤0.01% | 1337 |
|
|
2023
Q4 | $91.2M | Buy |
529,883
+437,185
| +472% | +$67.2M | 0.02% | 424 |
|
|
2023
Q3 | $13.7M | Sell |
92,698
-284,241
| -75% | -$51.4M | ﹤0.01% | 1442 |
|
|
2023
Q2 | $82.4M | Buy |
376,939
+309,374
| +458% | +$69M | 0.03% | 406 |
|
|
2023
Q1 | $14.8M | Buy |
67,565
+21,611
| +47% | +$4.69M | 0.01% | 1249 |
|
|
2022
Q4 | $9.56M | Sell |
45,954
-5,365
| -10% | -$1.18M | ﹤0.01% | 1666 |
|
|
2022
Q3 | $11.2M | Sell |
51,319
-46,060
| -47% | -$10.5M | ﹤0.01% | 1581 |
|
|
2022
Q2 | $20.4M | Buy |
+97,379
| New | +$20.7M | 0.01% | 1105 |
|
|
2022
Q1 | – | Sell |
-10,708
| Closed | -$2.59M | – | 10923 |
|
|
2021
Q4 | $2.79M | Sell |
10,708
-5,125
| -32% | -$1.33M | ﹤0.01% | 3814 |
|
|
2021
Q3 | $4.17M | Sell |
15,833
-68,307
| -81% | -$18.7M | ﹤0.01% | 3038 |
|
|
2021
Q2 | $20.7M | Buy |
84,140
+29,580
| +54% | +$6.22M | 0.01% | 1052 |
|
|
2021
Q1 | $10.6M | Buy |
54,560
+47,366
| +658% | +$9.5M | 0.01% | 1491 |
|
|
2020
Q4 | $1.53M | Sell |
7,194
-15,935
| -69% | -$3.18M | ﹤0.01% | 3982 |
|
|
2020
Q3 | $3.96M | Buy |
23,129
+5,519
| +31% | +$1.02M | ﹤0.01% | 2119 |
|
|
2020
Q2 | $3.38M | Buy |
17,610
+14,798
| +526% | +$2.42M | ﹤0.01% | 2336 |
|
|
2020
Q1 | $414K | Sell |
2,812
-783
| -22% | -$125K | ﹤0.01% | 3845 |
|
|
2019
Q4 | $557K | Buy |
3,595
+1,381
| +62% | +$199K | ﹤0.01% | 3566 |
|
|
2019
Q3 | $299K | Buy |
+2,214
| New | +$290K | ﹤0.01% | 4198 |
|
|
2019
Q2 | – | Sell |
-16,656
| Closed | -$1.73M | – | 5636 |
|
|
2019
Q1 | $1.73M | Buy |
16,656
+14,233
| +587% | +$1.47M | ﹤0.01% | 2184 |
|
|
2018
Q4 | $276K | Sell |
2,423
-3,310
| -58% | -$355K | ﹤0.01% | 4160 |
|
|
2018
Q3 | $661K | Sell |
5,733
-19,906
| -78% | -$2.18M | ﹤0.01% | 3289 |
|
|
2018
Q2 | $2.66M | Buy |
25,639
+22,390
| +689% | +$2.27M | 0.01% | 1615 |
|
|
2018
Q1 | $320K | Sell |
3,249
-2,642
| -45% | -$250K | ﹤0.01% | 3943 |
|
|
2017
Q4 | $499K | Buy |
+5,891
| New | +$487K | ﹤0.01% | 3178 |
|
|
2017
Q3 | – | Sell |
-3,117
| Closed | -$243K | – | 4954 |
|
|
2017
Q2 | $243K | Buy |
+3,117
| New | +$223K | ﹤0.01% | 3828 |
|
|
2016
Q4 | – | Sell |
-113,738
| Closed | -$7.37M | – | 4525 |
|
|
2016
Q3 | $7.37M | Buy |
113,738
+102,441
| +907% | +$6.82M | 0.04% | 415 |
|
|
2016
Q2 | $714K | Buy |
+11,297
| New | +$666K | ﹤0.01% | 2372 |
|
|
2016
Q1 | – | Sell |
-21,062
| Closed | -$1.13M | – | 4562 |
|
|
2015
Q4 | $1.13M | Sell |
21,062
-21,443
| -50% | -$1.21M | 0.01% | 1614 |
|
|
2015
Q3 | $2.17M | Buy |
+42,505
| New | +$2.29M | 0.01% | 911 |
|
|
2015
Q2 | – | Sell |
-40,746
| Closed | -$2.92M | – | 3969 |
|
|
2015
Q1 | $2.92M | Buy |
+40,746
| New | +$2.65M | 0.02% | 643 |
|
|
2014
Q2 | – | Sell |
-8,461
| Closed | -$378K | – | 3024 |
|
|
2014
Q1 | $378K | Sell |
8,461
-13,880
| -62% | -$623K | ﹤0.01% | 1797 |
|
|
2013
Q4 | $1.05M | Sell |
22,341
-17,624
| -44% | -$892K | 0.02% | 767 |
|
|
2013
Q3 | $2.11M | Buy |
39,965
+35,291
| +755% | +$1.71M | 0.03% | 549 |
|
|
2013
Q2 | $211K | Buy |
+4,674
| New | +$222K | ﹤0.01% | 2209 |
|
Other funds holding RMD
Jane Street's RMD Position: Q2 2026 in Review
Jane Street reduced its ResMed (RMD) stake by 18% in Q2 2026, selling an estimated $286K and leaving 6,211 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #6135.
Jane Street first reported a position in RMD in Q2 2013 and has held it in 43 quarters since. The position peaked at $91.2M in Q4 2023. 869 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Jane Street held 6,211 shares of ResMed worth $1.21M as of Q2 2026.
- Jane Street sold 1,378 ResMed shares in Q2 2026, an estimated $286K.
- ResMed made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6135 holding.
- Jane Street first reported a position in ResMed in Q2 2013 and has held it in 43 quarters since.
- Jane Street's ResMed position peaked at $91.2M in Q4 2023.
- 869 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.